Keyword: University of North Carolina
The week’s biotech discoveries included eight mutations that contribute to cardiomyopathy and an enzyme that promotes basal-like breast cancer.
Two discoveries related to a combination treatment and genetic testing could improve the prognosis for patients with pancreatic cancer.
Some microRNAs could serve as prognostic markers of Crohn's and open the possibility of developing personalized therapies.
Ovarian cancer has proved resistant to immunotherapy, but may be vulnerable to personalized T cell therapy using tumor-derived T cells.
Targeting a "highly prevalent" antigen could address the heterogeneity of glioblastomas.
Biotech discoveries over the past week included a key molecule in nerve cells in Parkinson’s and insights into the brain’s role in obesity.
UNC scientists unraveled the structure of an opioid receptor, which could allow for the design of painkillers that do not cause side effects.
The past week saw news of a partnership aimed at improving cancer discovery, a technique for reversing heart damage and a new cancer-killing cell.
North Carolina scientists are developing a skin patch containing “smart” beta cells that can detect the need for insulin and secrete it automatically.
Targeting a cell process that promotes protein clumping could lead to new drugs for ALS.